Risk of AKI with gentamicin as surgical prophylaxis

Journal of the American Society of Nephrology

Volumn 25, Issue 11, 2014, Pages 2625-2632

  Bell, Samira ^a,b   Davey, Peter ^b   Nathwani, Dilip ^c   Marwick, Charis ^b   Vadiveloo, Thenmalar ^b   Sneddon, Jacqueline ^c   Patton, Andrea ^c   Bennie, Marion ^d   Fleming, Stewart ^b   Donnan, Peter T ^b  

^a NINEWELLS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c DoH Advisory Committee on Antibiotic Resistance and Healthcare Acquired Infections   (United Kingdom)

^d UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFUROXIME; CREATININE; FLUCLOXACILLIN; GENTAMICIN; METRONIDAZOLE; ANTIINFECTIVE AGENT;

ACUTE KIDNEY FAILURE; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; FEMALE; GASTROINTESTINAL SURGERY; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE DRUG DOSE; SURGICAL INFECTION; UNITED KINGDOM; VASCULAR SURGERY; ABDOMINAL SURGERY; ACUTE KIDNEY INJURY; ADULT; ADVERSE EFFECTS; CHEMICALLY INDUCED; COMORBIDITY; DRUG EFFECTS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; GYNECOLOGIC SURGERY; MIDDLE AGED; ORTHOPEDIC SURGERY; PEPTOCLOSTRIDIUM DIFFICILE; RISK FACTOR; SCOTLAND; STATISTICS AND NUMERICAL DATA; UROLOGIC SURGERY; VERY ELDERLY;

ACUTE KIDNEY INJURY; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CLOSTRIDIUM DIFFICILE; COMORBIDITY; DIGESTIVE SYSTEM SURGICAL PROCEDURES; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; GENTAMICINS; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; INTERRUPTED TIME SERIES ANALYSIS; MALE; MIDDLE AGED; ORTHOPEDIC PROCEDURES; RISK FACTORS; SCOTLAND; UROLOGIC SURGICAL PROCEDURES; VASCULAR SURGICAL PROCEDURES;

EID: 84912555671     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014010035     Document Type: Article

References (29)

1. Liaño F, Junco E, Pascual J, Madero R, Verde E; The Madrid Acute Renal Failure Study Group: The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. Kidney Int Suppl 66: S16-S24, 1998
2. Cosentino F, Chaff C, Piedmonte M: Risk factors influencing survival in ICUacute renal failure. Nephrol Dial Transplant 9[Suppl 4]: 179-182, 1994
3. Levy EM, Viscoli CM, Horwitz RI: The effect of acute renal failure on mortality. A cohort analysis. JAMA 275: 1489-1494, 1996
4. Uchino S, Bellomo R, Goldsmith D, Bates S, Ronco C: An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med 34: 1913-1917, 2006
5. Lameire NH, Bagga A, Cruz D, De Maeseneer J, Endre Z, Kellum JA, Liu KD, Mehta RL, Pannu N, Van Biesen W, Vanholder R: Acute kidney injury: An increasing global concern. Lancet 382: 170-179, 2013
6. Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ: Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother 67: 742-748, 2012
7. Carignan A, Allard C, Pepin J, Cossette B, Nault V, Valiquette L: Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain. Clin Infect Dis 46: 1838-1843, 2008
8. McGuire M, Keel A, Scott B: A Revised Framework for National Surveillance of Healthcare Associated Infection and the Introduction of a New Health Efficiency and Access to Treatment (HEAT) Target for Clostridium difficile Associated Disease (CDAD) for NHS Scotland. Edinburgh, UK, Scottish Government Health Department, 2009
9. Scottish Antimicrobial Prescribing Group: Guidance to Optimise Antimicrobial Use and Reduce Clostridium difficile Associated Disease in Scottish Hospitals. Edinburgh, UK, Scottish Government Health Department, 2008
10. Challagundla SR, Knox D, Hawkins A, Hamilton D, W V Flynn R, Robertson S, Isles C: Renal impairment after high-dose flucloxacillin and single-dose gentamicin prophylaxis in patients undergoing elective hip and knee replacement. Nephrol Dial Transplant 28: 612-619, 2013
11. Higgins JPT, Ramsay C, Reeves BC, Deeks JJ, Shea B, Valentine JC, Tugwell P, Wells G: Issues relating to study design and risk of bias when including non-randomized studies in systematic reviews on the effects of interventions. Research Synthesis Methods 4: 12-25, 2012
12. Ramsay CR, Matowe L, Grilli R, Grimshaw JM, Thomas RE: Interrupted time series designs in health technology assessment: Lessons from two systematic reviews of behavior change strategies. Int J Technol Assess Health Care 19: 613-623, 2003
13. Thakar CV, Christianson A, Freyberg R, Almenoff P, Render ML: Incidence and outcomes of acute kidney injury in intensive care units: A Veterans Administration study. Crit Care Med 37: 2552-2558, 2009
14. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators: Acute renal failure in critically ill patients: A multinational, multicenter study. JAMA 294: 813-818, 2005
15. Thakar CV: Perioperative acute kidney injury. Adv Chronic Kidney Dis 20: 67-75, 2013Z
16. KDIGO Clinical Practice Guideline for Acute Kidney Injury Work Group: KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2: 1-138, 2012
17. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW: Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16: 3365-3370, 2005
18. Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR: Long-term risk of mortality and other adverse outcomes after acute kidney injury: A systematic review and meta-analysis. Am J Kidney Dis 53: 961-973, 2009
19. Pusey CD, Saltissi D, Bloodworth L, Rainford DJ, Christie JL: Drug associated acute interstitial nephritis: Clinical and pathological features and the response to high dose steroid therapy. Q J Med 52: 194-211, 1983
20. Zahar JR, Rioux C, Girou E, Hulin A, Sauve C, Bernier-Combes A, Brun-Buisson C, Lesprit P: Inappropriate prescribing of aminoglycosides: Risk factors and impact of an antibiotic control team. J Antimicrob Chemother 58: 651-656, 2006
21. Lopez-Novoa JM, Quiros Y, Vicente L, Morales AI, Lopez-Hernandez FJ: New insights into the mechanism of aminoglycoside nephrotoxicity: An integrative point of view. Kidney Int 79: 33-45, 2011
22. Bliziotis IA, Michalopoulos A, Kasiakou SK, Samonis G, Christodoulou C, Chrysanthopoulou S, Falagas ME: Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: A meta-analysis of randomized controlled trials. Mayo Clin Proc 80: 1146-1156, 2005
23. Falagas ME, Matthaiou DK, Bliziotis IA: The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: A meta-analysis of comparative trials. J Antimicrob Chemother 57: 639-647, 2006
24. Falagas ME, Matthaiou DK, Karveli EA, Peppas G: Meta-analysis: Randomized controlled trials of clindamycin/aminoglycoside vs. betalactam monotherapy for the treatment of intra-abdominal infections. Aliment Pharmacol Ther 25: 537-556, 2007
25. Paul M, Benuri-Silbiger I, Soares-Weiser K, Leibovici L: Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: Systematic review and meta-analysis of randomised trials. BMJ 328: 668, 2004
26. University of Dundee: Health Informatics Centre. Available at http://www.medicine.dundee.ac.uk/hic. Accessed March 24, 2014
27. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40: 373-383, 1987
28. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D: Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 27: 299-309, 2002
29. Durbin J, Watson GS: Testing for serial correlation in least squares regression. I. Biometrika 37: 409-428, 1950